Proteolysis and autolysis of proteases and the detection of degradation products in doping control
Authors:
- 1 February 2009
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 1 (2) , 81-86
Abstract
The determination of protein‐ or peptide‐based performance‐enhancing pharmaceuticals has gained increasing attention in sports drug testing in recent decades. Proteases possess a high potential for use in the manipulation of regular urine specimens, interfering with established doping control procedures for proteins or peptides. Hence, the present approach was developed to identify degradation products directly from proteases with exogenous origin in urine samples by means of SDS‐PAGE and capillary liquid chromatography—Orbitrap (tandem) mass spectrometry. The mass spectrometric identification was accomplished by database search considering the accurate monoisotopic precursor mass with data dependent MS/MS analysis and no setting for specific cleavage site(s) or enzyme(s). The main characteristics of the method were shown in an exemplary way for the proteases Papain, Bacillolysin, Trypsin and Subtilisin with sufficient results for specificity, limit of detection, working range, precision and recovery after incubation. All experiments were performed with fortified urine samples under consideration of assumed realistic conditions for adulteration by cheating sportsmen. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 12 references indexed in Scilit:
- Mass spectrometry for monitoring protease reactionsAnalytical and Bioanalytical Chemistry, 2008
- Discrimination of Recombinant and Endogenous Urinary Erythropoietin by Calculating Relative Mobility Values from SDS GelsInternational Journal of Sports Medicine, 2007
- Possible origins of undetectable EPO in urine samplesClinica Chimica Acta, 2007
- Proteases in Doping Control AnalysisInternational Journal of Sports Medicine, 2007
- Mass Spectrometric Identification of Degradation Products of Insulin and Its Long-Acting Analogues in Human Urine for Doping Control PurposesAnalytical Chemistry, 2007
- Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testingRapid Communications in Mass Spectrometry, 2007
- Doping Control Analysis of Intact Rapid-Acting Insulin Analogues in Human Urine by Liquid Chromatography−Tandem Mass SpectrometryAnalytical Chemistry, 2006
- Establishment of a near‐standard two‐dimensional human urine proteomic mapProteomics, 2004
- Purification and Characterization of Proteases from Bacillus amyloliquefaciens Isolated from Traditional Soybean Fermentation StarterJournal of Agricultural and Food Chemistry, 2003
- Test method: GHBest Practice & Research Clinical Endocrinology & Metabolism, 2000